Search results for "Diabetic macular edema"
Aflibercept approved for diabetic retinopathy in diabetic macular edema
Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.
https://diabetes.acponline.org/archives/2015/04/10/7.htm
10 Apr 2015
Results appear similar at 2 years for diabetic macular edema drugs
Eyes were assigned to receive 2.0 mg aflibercept, 1.25 mg repackaged (compounded) bevacizumab, or 0.3 mg ranibizumab. Intravitreous injections were administered up to once per month according to a follow-up and retreatment regimen specified by protocol.
https://diabetes.acponline.org/archives/2016/03/11/3.htm
11 Mar 2016
Spotlight on diabetic macular edema
Two recent studies analyzed treatment of diabetic macular edema with drugs that block vascular endothelial growth factor.
https://diabetes.acponline.org/archives/2015/03/13/10.htm
13 Mar 2015
Cystatin C levels associated with risk of sight-threatening diabetic retinopathy
The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
https://diabetes.acponline.org/archives/2022/05/13/3.htm
13 May 2022
Spotlight on artificial intelligence and diabetic retinopathy
One recent study reported on the development and validation of an artificial intelligence algorithm for detecting diabetic retinopathy, while another tested such technology in primary care.
https://diabetes.acponline.org/archives/2018/10/12/6.htm
12 Oct 2018
Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy
A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
https://diabetes.acponline.org/archives/2021/01/08/2.htm
8 Jan 2021
Macular edema, cardiovascular disease associated in type 2 diabetes
Patients with diabetic macular edema or proliferative diabetic retinopathy should be followed more actively to prevent cardiovascular disease, study authors said.
https://diabetes.acponline.org/archives/2017/05/12/1.htm
12 May 2017
Possible link between thiazolidinediones, macular edema
Patients with type 2 diabetes who are treated with a thiazolidinedione may have an increased risk for diabetic macular edema, according to a recent study.
https://diabetes.acponline.org/archives/2012/07/13/3.htm
13 Jul 2012
New drugs approved for diabetes
The first generic version of pioglitazone hydrochloride (Actos) and a new indication for ranibizumab injection (Lucentis) were recently announced by the FDA.
https://diabetes.acponline.org/archives/2012/11/09/9.htm
9 Nov 2012
Glucose monitoring app, weight-loss device, medications approved
The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.
https://diabetes.acponline.org/archives/2015/02/13/7.htm
13 Feb 2015